Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03246399
What this trial is testing

The Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease

Who this might be right for
Degenerative Disc Disease
Biosplice Therapeutics, Inc. 6
Early research (Phase 1)Active Not RecruitingNCT07052032
What this trial is testing

An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Candid Therapeutics 47
Early research (Phase 1)UnknownNCT04740398
What this trial is testing

CBP-1008 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Coherent Biopharma (Suzhou) Co., Ltd. 143
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018063
What this trial is testing

Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer

Who this might be right for
Gastric (Cardia, Body) CancerStomach AdenocarcinomaLocally Advanced
zhoujing 35
Not applicableUnknownNCT04936763
What this trial is testing

To Assess The Performance And Tolerance Of Janesse 20 In The Volume Restoration Of Labia Majora

Who this might be right for
Dysmorphic Disorder (BDD)Congenital Labia Majora HypotrophyPost-menopausal Labia Majora Hypotrophy
I.R.A. Istituto Ricerche Applicate S.p.A. 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06757387
What this trial is testing

Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Peking University Cancer Hospital & Institute 45
Large-scale testing (Phase 3)Study completedNCT03764293
What this trial is testing

Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Who this might be right for
Locally Advanced or Metastatic and Unresectable HCC
Jiangsu HengRui Medicine Co., Ltd. 543
Post-approval studies (Phase 4)Study completedNCT00160121
What this trial is testing

Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

Who this might be right for
Kidney Failure, Chronic
Shire 2,500
Testing effectiveness (Phase 2)Ended earlyNCT01095887
What this trial is testing

Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplant
Mayo Clinic 6
Early research (Phase 1)Study completedNCT02128893
What this trial is testing

Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole

Who this might be right for
Pharmacokinetics of IsavuconazoleHealthy Subjects
Astellas Pharma Global Development, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01061216
What this trial is testing

Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Becton, Dickinson and Company 20
Early research (Phase 1)Study completedNCT04572295
What this trial is testing

E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Co., Ltd. 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT07807995
What this trial is testing

Open-Label Study of Long-term Treatment With Povetacicept in Adults With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Vertex Pharmaceuticals Incorporated 605
Large-scale testing (Phase 3)Study completedNCT00915577
What this trial is testing

Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe

Who this might be right for
Multiple Sclerosis
Biogen 74
Large-scale testing (Phase 3)Active Not RecruitingNCT05132075
What this trial is testing

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 95
Large-scale testing (Phase 3)Study completedNCT03452475
What this trial is testing

Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children

Who this might be right for
Plasmodium Falciparum
University of Oxford 219
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Large-scale testing (Phase 3)Study completedNCT00146328
What this trial is testing

Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects

Who this might be right for
HIV Infections
Boehringer Ingelheim 997
Early research (Phase 1)Study completedNCT01565928
What this trial is testing

Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 23
Testing effectiveness (Phase 2)Study completedNCT03548207
What this trial is testing

JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 126
Next Page